Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection rate

La Raja Massimo, Pacenti Monia, Grimaldi Ileana, Boldrin Caterina, Cattai Margherita, Solimbergo Erica, Battisti Anna, Scomazzon Michele, Roman Alberto, Lazzaro Anna Rosa, Vicari Stefano, Terzariol Stefano, De Silvestro Giustina
doi: https://doi.org/10.1101/2021.07.13.21260414
La Raja Massimo
1Transfusion Medicine Department of Padova, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: massimo.laraja{at}aopd.veneto.it
Pacenti Monia
2Microbiologiy and Virology, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grimaldi Ileana
2Microbiologiy and Virology, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boldrin Caterina
2Microbiologiy and Virology, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cattai Margherita
2Microbiologiy and Virology, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Solimbergo Erica
3Transfusion Medicine Department of Padova, Azienda ULSS 6 Euganea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Battisti Anna
3Transfusion Medicine Department of Padova, Azienda ULSS 6 Euganea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scomazzon Michele
3Transfusion Medicine Department of Padova, Azienda ULSS 6 Euganea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Alberto
3Transfusion Medicine Department of Padova, Azienda ULSS 6 Euganea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lazzaro Anna Rosa
1Transfusion Medicine Department of Padova, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicari Stefano
4Azienda ULSS 6 Euganea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terzariol Stefano
1Transfusion Medicine Department of Padova, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
De Silvestro Giustina
1Transfusion Medicine Department of Padova, Azienda Ospedale-Università di Padova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

From April 2020 through May 2021 in Padova Province 3395 COVID-19 recovered patients were recruited as potential convalescent plasma donors and tested for SARS-CoV-2 antibodies. Since January 2021 COVID-19 vaccination campaign began in Italy, the impact of vaccination on antibody levels and suspect vaccine breakthrough infections in these subjects were investigated. Post-vaccination anti-Sars-Cov-2 antibody level in 54 previously infected subjects had an exponential increase compared to pre-vaccination level regardless of the number of vaccine doses. However after 100 days from vaccination SARS-CoV-2 antibody level tends to decline. Post-vaccination primary infections were detected in 15 cases, with 3 possible breakthrough infections after a full vaccination course. In these cases, antibody response after infection was present but weaker than the one of subjects vaccinated after natural infection. A trend toward stronger antibody response was observed with increasing distance between natural infection and vaccination. Additionally, 2 cases of asymptomatic reinfections are also discussed.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

This is an observational study on convalescent plasma donors as part of the Study Protocol on Covalescent Plasma that has been approved by the Ethics Committee (EC) of the Padova University Hospital, Details on the protocol were already described elsewere https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103741/

Funding Statement

Funding of convalescent plasma activities was provided by the Regione del Veneto.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The present study is a part of the study protocol : Interventional study to evaluate the efficacy of treatment with plasma, collected from recovered COVID-19 patients (convalescent plasma or hyperimmune plasma), in patients with severe COVID-19 infection, authorised by the ethics committee of the hospital of Padua, the Italian National Blood Centre, and the Veneto region

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are available in the Padova transfusion department database and Padova University Hospital Microbiology and Virology service information system

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted July 19, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection rate
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection rate
La Raja Massimo, Pacenti Monia, Grimaldi Ileana, Boldrin Caterina, Cattai Margherita, Solimbergo Erica, Battisti Anna, Scomazzon Michele, Roman Alberto, Lazzaro Anna Rosa, Vicari Stefano, Terzariol Stefano, De Silvestro Giustina
medRxiv 2021.07.13.21260414; doi: https://doi.org/10.1101/2021.07.13.21260414
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 convalescent plasma donors: impact of vaccination on antibody levels, breakthrough infections and reinfection rate
La Raja Massimo, Pacenti Monia, Grimaldi Ileana, Boldrin Caterina, Cattai Margherita, Solimbergo Erica, Battisti Anna, Scomazzon Michele, Roman Alberto, Lazzaro Anna Rosa, Vicari Stefano, Terzariol Stefano, De Silvestro Giustina
medRxiv 2021.07.13.21260414; doi: https://doi.org/10.1101/2021.07.13.21260414

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)